{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:00:56Z","timestamp":1781146856507,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21802035"],"award-info":[{"award-number":["21802035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jcis.2023.01.144","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:02:17Z","timestamp":1675339337000},"page":"375-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["A multifunctional nanotheranostic agent based on Lenvatinib for multimodal synergistic hepatocellular carcinoma therapy with remarkably enhanced efficacy"],"prefix":"10.1016","volume":"638","author":[{"given":"Qi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zushun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcis.2023.01.144_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.jcis.2023.01.144_b0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000507022","article-title":"Potential of lenvatinib for an expanded indication from the REFLECT trial in patients with advanced hepatocellular carcinoma","volume":"9","author":"Maruta","year":"2020","journal-title":"Liver Cancer"},{"issue":"6","key":"10.1016\/j.jcis.2023.01.144_b0015","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/cam4.1517","article-title":"Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models","volume":"7","author":"Matsuki","year":"2018","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: from preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"10.1016\/j.jcis.2023.01.144_b0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40265-019-01116-x","article-title":"Lenvatinib: a review in hepatocellular carcinoma","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1073274818789361","article-title":"Lenvatinib: a promising molecular targeted agent for multiple cancers","volume":"25","author":"Suyama","year":"2018","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.jcis.2023.01.144_b0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1158\/1078-0432.CCR-15-1354","article-title":"Safety and pharmacokinetics of lenvatinib in patients with advanced hepatocellular carcinoma","volume":"22","author":"Ikeda","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12209","article-title":"Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting","volume":"4","author":"Sho","year":"2020","journal-title":"JGH Open"},{"issue":"11","key":"10.1016\/j.jcis.2023.01.144_b0045","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14740338.2018.1530212","article-title":"Optimal management of patients with hepatocellular carcinoma treated with lenvatinib","volume":"17","author":"Ikeda","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"issue":"13","key":"10.1016\/j.jcis.2023.01.144_b0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3747\/co.27.7159","article-title":"Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease","volume":"27","author":"Perera","year":"2020","journal-title":"Curr. Oncol."},{"issue":"12","key":"10.1016\/j.jcis.2023.01.144_b0055","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1111\/cas.13806","article-title":"Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model","volume":"109","author":"Kimura","year":"2018","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.jcis.2023.01.144_b0060","first-page":"3719","article-title":"Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions\u2014multicenter analysis","volume":"8","author":"Hiraoka","year":"2019","journal-title":"CancerMed."},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-96089-x","article-title":"Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study","volume":"11","author":"Hiraoka","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jcis.2023.01.144_b0070","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/cancers14020320","article-title":"Analysis of survival and response to lenvatinib in unresectable hepatocellular carcinoma","volume":"14","author":"Amioka","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jcis.2023.01.144_b0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.14479","article-title":"Clinical efficacy of lenvatinib for the treatment of radioiodine-refractory thyroid carcinoma: a systematic review and meta-analysis of clinical trials","volume":"95","author":"Yan","year":"2021","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jcis.2023.01.144_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-021-03815-z","article-title":"The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study","author":"Chen","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol"},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jcis.2023.01.144_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111103","article-title":"Nanomedicines: redefining traditional medicine","volume":"134","author":"Lu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000512239","article-title":"Efficacy and safety of lenvatinib therapy for unresectable hepatocellular carcinoma in a real-world practice in Korea","volume":"10","author":"Goh","year":"2021","journal-title":"Liver Cancer"},{"issue":"12","key":"10.1016\/j.jcis.2023.01.144_b0100","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1245\/s10434-021-09974-0","article-title":"Prognostic impact of surgical intervention after lenvatinib treatment for advanced hepatocellular carcinoma","volume":"28","author":"Shindoh","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jcis.2023.01.144_b0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2023.01.144_b0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jddst.2017.04.019","article-title":"Nanocarrier mediated combination drug delivery for chemotherapy \u2013 a review","volume":"39","author":"Pushpalatha","year":"2017","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jcis.2023.01.144_b0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jcis.2023.01.144_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nantod.2020.100946","article-title":"Recent progress of chemodynamic therapy-induced combination cancer therapy","volume":"35","author":"Wang","year":"2020","journal-title":"Nano Today"},{"issue":"45","key":"10.1016\/j.jcis.2023.01.144_b0125","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.jcis.2023.01.144_b0130","doi-asserted-by":"crossref","first-page":"e2002439","DOI":"10.1002\/adma.202002439","article-title":"GSH-depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy","volume":"32","author":"Dong","year":"2020","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jcis.2023.01.144_b0135","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/acs.chemrev.0c00977","article-title":"Biomedicine meets fenton chemistry","volume":"121","author":"Tang","year":"2021","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.jcis.2023.01.144_b0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jcis.2023.01.144_b0145","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.scitotenv.2018.08.022","article-title":"Novel flexible Fenton-like catalyst: unique CuO nanowires arrays on copper mesh with high efficiency across a wide pH range","volume":"647","author":"Su","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jcis.2023.01.144_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biomaterials.2019.03.014","article-title":"Ultrasmall Cu2-xS nanodots as photothermal-enhanced Fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow","volume":"206","author":"Hu","year":"2019","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.jcis.2023.01.144_b0155","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1021\/acs.chemmater.9b01958","article-title":"Hollow cu2se nanozymes for tumor photothermal-catalytic therapy","volume":"31","author":"Wang","year":"2019","journal-title":"Chem. Mater."},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0160","doi-asserted-by":"crossref","DOI":"10.1007\/s40820-020-0378-6","article-title":"Deep-tissue photothermal therapy using laser illumination at NIR-IIa window","volume":"12","author":"Wu","year":"2020","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.jcis.2023.01.144_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120279","article-title":"Biomimetic CoO@ AuPt nanozyme responsive to multiple tumor microenvironmental clues for augmenting chemodynamic therapy","volume":"257","author":"Fu","year":"2020","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.jcis.2023.01.144_b0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nnano.2009.235","article-title":"Diagnosing lung cancer in exhaled breath using gold nanoparticles","volume":"4","author":"Peng","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jcis.2023.01.144_b0175","doi-asserted-by":"crossref","unstructured":"D. Suresh, A. Suresh, R.J.B.m. Kannan, Engineering biomolecular systems: controlling the self-assembly of gelatin to form ultra-small bioactive nanomaterials 18 (2022) 321\u2013336.","DOI":"10.1016\/j.bioactmat.2022.02.035"},{"key":"10.1016\/j.jcis.2023.01.144_b0180","doi-asserted-by":"crossref","unstructured":"J. Xu, M. Song, Z. Fang, L. Zheng, X. Huang, K.J.J.o.C.R. Liu, Applications and challenges of ultra-small particle size nanoparticles in tumor therapy 353 (2023) 699\u2013712.","DOI":"10.1016\/j.jconrel.2022.12.028"},{"key":"10.1016\/j.jcis.2023.01.144_b0185","doi-asserted-by":"crossref","unstructured":"K. Siwawannapong, R. Zhang, H. Lei, Q. Jin, W. Tang, Z. Dong, R.-Y. Lai, Z. Liu, A. Kamkaew, L.J.T. Cheng, Ultra-small pyropheophorbide-a nanodots for near-infrared fluorescence\/photoacoustic imaging-guided photodynamic therapy 10(1) (2020) 62","DOI":"10.7150\/thno.35735"},{"issue":"48","key":"10.1016\/j.jcis.2023.01.144_b0190","doi-asserted-by":"crossref","first-page":"9908","DOI":"10.1039\/D1TB01808F","article-title":"Lenvatinib and Cu2\u2013xS nanocrystals co-encapsulated in poly (d,l-lactide-co-glycolide) for synergistic chemo-photothermal therapy against advanced hepatocellular carcinoma","volume":"9","author":"Xu","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.jcis.2023.01.144_b0195","doi-asserted-by":"crossref","DOI":"10.1088\/2053-1591\/ab80ea","article-title":"Low-cost synthesis of AuNPs through ultrasonic spray pyrolysis","volume":"7","author":"Tiyyagura","year":"2020","journal-title":"Mater. Res. Express"},{"key":"10.1016\/j.jcis.2023.01.144_b0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jphotobiol.2017.01.008","article-title":"Guazuma ulmifolia bark-synthesized Ag, Au and Ag\/Au alloy nanoparticles: photocatalytic potential, DNA\/protein interactions, anticancer activity and toxicity against 14 species of microbial pathogens","volume":"167","author":"Karthika","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jcis.2023.01.144_b0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matlet.2015.12.031","article-title":"Facile one-step green synthesis of gold nanoparticles using Citrus maxima aqueous extracts and its catalytic activity","volume":"166","author":"Yu","year":"2016","journal-title":"Mater. Lett."},{"issue":"21","key":"10.1016\/j.jcis.2023.01.144_b0210","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1039\/C4RA14988B","article-title":"Green synthesis of gold nanoparticles and its application for the trace level determination of painter's colic","volume":"5","author":"Karuppiah","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jcis.2023.01.144_b0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1039\/C39940000801","article-title":"Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid\u2013liquid system","volume":"7","author":"Brust","year":"1994","journal-title":"J. Chem. Soc. Chem. Commun."},{"issue":"46","key":"10.1016\/j.jcis.2023.01.144_b0220","doi-asserted-by":"crossref","first-page":"54770","DOI":"10.1021\/acsami.1c16835","article-title":"Boosting chemodynamic therapy via a synergy of hypothermal ablation and oxidation resistance reduction","volume":"13","author":"Yao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jcis.2023.01.144_b0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jconrel.2019.06.026","article-title":"Intravital microscopy reveals a novel mechanism of nanoparticles excretion in kidney","volume":"307","author":"Naumenko","year":"2019","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jcis.2023.01.144_b0230","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.iecr.9b04747","article-title":"Formulation of nanoparticles using mixing-induced nanoprecipitation for drug delivery","volume":"59","author":"Liu","year":"2019","journal-title":"Ind. Eng. Chem. Res."},{"issue":"1","key":"10.1016\/j.jcis.2023.01.144_b0235","first-page":"1","article-title":"Functionalizing PLGA and PLGA derivatives for drug delivery and tissue regeneration applications","volume":"7","author":"Martins","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"33","key":"10.1016\/j.jcis.2023.01.144_b0240","doi-asserted-by":"crossref","first-page":"13169","DOI":"10.1039\/C6DT01434H","article-title":"Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy","volume":"45","author":"Muhammad","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jcis.2023.01.144_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.023","article-title":"Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy","volume":"211","author":"Qian","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jcis.2023.01.144_b0250","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/cm4035598","article-title":"Generalized one-pot synthesis of copper sulfide, selenide-sulfide, and telluride-sulfide nanoparticles","volume":"26","author":"Saldanha","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jcis.2023.01.144_b0255","doi-asserted-by":"crossref","unstructured":"I. Hussain, S. Graham, Z. Wang, B. Tan, D.C. Sherrington, S.P. Rannard, A.I. Cooper, M.J.J.o.t.A.C.S. Brust, Size-controlled synthesis of near-monodisperse gold nanoparticles in the 1\u22124 nm range using polymeric stabilizers 127(47) (2005) 16398\u201316399.","DOI":"10.1021\/ja055321v"},{"issue":"10","key":"10.1016\/j.jcis.2023.01.144_b0260","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/adhm.201500273","article-title":"A near infrared light triggered hydrogenated black TiO2 for cancer photothermal therapy","volume":"4","author":"Ren","year":"2015","journal-title":"Adv. Healthc. Mater."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002197972300173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002197972300173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:44:48Z","timestamp":1762195488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002197972300173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":52,"alternative-id":["S002197972300173X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2023.01.144","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multifunctional nanotheranostic agent based on Lenvatinib for multimodal synergistic hepatocellular carcinoma therapy with remarkably enhanced efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2023.01.144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}